NOV 24, 2018 10:54 PM PST

New Anti-Malarial Drug Target in Cancer

WRITTEN BY: Nouran Amin

For decades, anti-malaria drugs--known as Chloroquines, have used to treat cancer. But the role in repurposing these drugs for slowing tumor growth have never been quite understood until a recent research study in Cancer Discovery.

Credit: NaturalNews.com

The research, carried at out Abramson Cancer Center of the University of Pennsylvania, identified the chloroquines specific target in cancer – an enzyme called PPT1. Identifying that particular enzyme has opened the doors for potential cancer treatments. “The discovery of this target is critical because chloroquines are currently being evaluated in clinical trials all over the world, including here at Penn, and this knowledge fundamentally changes the way we look at those trials,” says study co-senior author and associate professor--Dr Ravi K. Amaravadi of the Perelman School of Medicine at the University of Pennsylvania.

The enzyme, PPT1, controls the target of rapamycin (mTOR)—which is highly involved in the growth of cancer cells as well as another cellular process known as autophagy—a way for cancer cells to detoxify and repair themselves. The mechanisms of autophagy was discovered by Nobel Prize winner-- Yoshinori Ohsumi, watch the video below to learn more:

In previous studies, autophagy was found to provide nutrient support for mTOR to direct cancer growth while, interestingly, mTOR was found to shut down autophagy when nutrients aren’t needed. Using these studies, the researchers utilized CRISPR/Cas9 gene editing approach to knockout PPT1 from cancer cells and observe if the same effects in earlier research can be seen. Results showed that indeed removing ppt1 does slow tumor growth. “The edited cells look like they’ve been treated with a drug, and they grow significantly slower than the unedited cells,” Prof Amaravadi said. “We also compiled data from existing databases and found PPT1 is both highly expressed in most cancers and also associated with poor outcomes.”

These findings encouraged researchers to develop potent chloroquine known as DC661, that will take advantage of this novel treatment pathway.

“We now have a specific molecular target in cancer, as well as a potent way to reach it,” Prof Amaravadi said. “It not only provides new context for current clinical trials involving hydroxychloroquine, but also, with further development of these compounds toward clinical drug candidates, it opens the door for head-to-head testing of our compounds or their optimized derivatives versus current chloroquines to see which is more effective.”

Source: Drug Target Review

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 07, 2018
Drug Discovery
NOV 07, 2018
Modifying Antibiotics For Drug Resistant Infections
In a study published in Nature Chemistry, researches at MIT were able to create a new chemical reaction that has the ability to modify antibiotics to make ...
NOV 21, 2018
Microbiology
NOV 21, 2018
Human Antibody That can Neutralize West Nile Virus is Found
In 1999, there were 62 cases of West Nile Virus in New York State. Since then it has spread around the United States....
DEC 05, 2018
Videos
DEC 05, 2018
Male Contraceptive Gel is in Clinical Trials
Researchers have started a clinical trial involving 420 participants to test the efficacy of a male contraceptive gel....
DEC 18, 2018
Drug Discovery
DEC 18, 2018
Increasing Misuse of Prescription Drugs
According to a study published in Psychiatric Services in Advance, misuse of prescription drugs accounts for more than 17 percent of overall use. In the st...
DEC 23, 2018
Drug Discovery
DEC 23, 2018
Preventive Drug Decreases Cases of Leprosy in Morocco
Leprosy, also known as Hansen disease, is a disabling chronic and infectious disease that affects the skin and the peripheral nerves. It has a huge effect ...
JAN 11, 2019
Drug Discovery
JAN 11, 2019
Histamine Improves Long-Term Memory
A recent research study found that histamine could improve people’s long-term memory which may be a prospective treatment option to alleviate symptom...
Loading Comments...